课题基金 / 基金详情

A study in the mechanism of cell fusion and giant cell fromation in skin diseases

A study in the mechanism of cell fusion and giant cell fromation in skin diseases
皮肤病细胞融合与巨细胞形成机制研究
批准号:
09670875
负责人:
MIZUTANI Hitoshi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

MIZUTANI Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
为了阐明真皮多核巨细胞形成的机制,我们研究了融合调节蛋白-1(FRP-1)在全身性和皮肤慢性炎症性疾病皮损中的表达。免疫组化研究显示,FRP-1的膜表达增强的早期阶段这些皮肤病的炎症浸润。结合胞体的形成,在成熟的巨细胞中,FRP-1的表达明显下调,膜FRP-1的表达消失。随后,体外培养的单核细胞脉冲与功能性抗FRP-1单克隆抗体诱导免疫反应性FRP-1的表达,其表达增强时间依赖性,直到合胞体形成。细胞融合后膜FRP-1表达明显下调,在形成的巨细胞中不再检测到FRP-1表达。这些结果证实了活性FRP-1膜蛋白参与单核细胞的合胞体形成,并且膜FRP-1的下调是过大的巨细胞形成的有效保护机制。
英文摘要
To declare the mechanism of dermal multinuclear giant cells formation, we investigated fusion regulatory protein-1 (FRP-1) expression in the skin lesions of the systemic and cutaneous chronic inflammatory diseases. Immunohistological investigation using anti-FRP-1 monoclonal antibody revealed augmentation of membranous expression of FRP-1 in the inflammatory infiltrates of the early phaselesion of these skin diseases. According to the syncytium formation, the immunoreactive FRP-1 expression was down regulated significantly, and the membrane FRP-1 was no more detective in the matured giant cells. Subsequent, invitro cultured monocytes pulsed with a functional anti-FRP-1 monoclonal antibody induced immunoreactive FRP-1 expression, and its expression was augmented time dependently until the syncytium formation. In contrast, membrane FRP-1expression was downregulated significantly after cell fusion, and it was no more detective in the formed giant cells. These results confirmed involvement of the active FRP-1 membrane protein in the syncytium formation of monocytes and downregulation of membrane FRP-1 is a potent protective mechanism for over-sized giant cell formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Isoda,K: "EB virus-related angiocentric T-cell lymphoma" Int J Dermatol. 37. 39-41 (1998)
Isoda,K:“EB 病毒相关的血管中心 T 细胞淋巴瘤”Int J Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi,M: "A case of multicentric reticulohistiocytosis systemic sclerosis and Sjogren syndrome" J Dermatol. 24. 530-534 (1987)
Takahashi,M:“多中心网状组织细胞增多症系统性硬化症和干燥综合征一例”J Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizutani,H: "Complete remission of recalcitrant polyarteritis nodosa after combination chemotherapy for accompanying B-cell non-Hodgkin lymphoma" Int J Dermatol. 37. 398-389 (1998)
Mizutani,H:“顽固性结节性多动脉炎在伴随 B 细胞非霍奇金淋巴瘤的联合化疗后完全缓解”Int J Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tabata, N.: "Protein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160" Medical Microbiology & Immunology. 186. 115-123 (1997)
Tabata, N.:“蛋白酪氨酸激酶激活在抗 FRP-1/CD98/4F2 单克隆抗体诱导的 HIV gp160 介导的细胞融合中提供了早期和必需的信号”医学微生物学
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Investigation of the mechanism and therapy for Japanese cedar pollen dermatitis
    • 批准号:
      24591647
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      MIZUTANI Hitoshi
    • 依托单位:
    Control of allergy with skin based immunomodulation
    • 批准号:
      21591461
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      MIZUTANI Hitoshi
    • 依托单位:
    Effects of the mutant cytokine therapy in atopic dermatitis
    • 批准号:
      18591242
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.45万
    • 财政年份:
      2006
    • 负责人:
      MIZUTANI Hitoshi
    • 依托单位:
    A study for atopic dermatitis controlledby Caspase-1 and IL-18
    • 批准号:
      13470171
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2001
    • 负责人:
      MIZUTANI Hitoshi
    • 依托单位:
    海外基金